Efficacy of omalizumab in adult patients with allergic bronchopulmonary aspergillosis: a multicentre study in China

Peixv Chen(Ningbo University), Chao Cao(University of Washington), Yiting Li(Ningbo University), Chunyi Zhang(Guangdong Province Women and Children Hospital), Di Wu(National Institutes of Health), He Li(Yangtze University), Yali Yu(Wuhan University), Guopeng Xu(Suzhou Municipal Hospital), Ran Wang(Central South University), Ying Chen(Nanjing Medical University)
Clinical and Experimental Medicine
January 19, 2024
10.1007/s10238-023-01267-y
Cited by 9

Related Papers

Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.1k
Plasmonic Nanozymes: Leveraging Localized Surface Plasmon Resonance to Boost the Enzyme‐Mimicking Activity of Nanomaterials
|Small|2022|84
Electron Lock Manipulates the Catalytic Selectivity of Nanozyme
|ACS Nano|2024|66
Coupling doping and localized surface plasmon resonance toward acidic pH-preferential catalase-like nanozyme for oxygen-dominated synergistic cancer therapy
|Chemical Engineering Journal|2023|61
STAT1 epigenetically regulates LCP2 and TNFAIP2 by recruiting EP300 to contribute to the pathogenesis of inflammatory bowel disease
|Clinical Epigenetics|2021|46